Table 2 The list of characterized off-targets having significant binding efficiency towards gefitinib compared to their respective reported ligands.

From: Identification of gefitinib off-targets using a structure-based systems biology approach; their validation with reverse docking and retrospective data mining

S. No.

Name

PDB

Ligand present in co-crystal

gefitinib MM-GBSA binding energy

known ligands MM-GBSA binding energy

∆Ggef/∆Glig

IC50 (nM) of known ligand

1

Cyclin-dependent kinase 2

2UZD

C85

−86.307

−20.274

4.257028707

ND

2

Cyclin-dependent kinase 2

2VTQ

LZA

−74.582

−19.222

3.880033295

ND

3

Fibroblast growth factor receptor 2

3RI1

3RH

−77.977

−28.889

2.699193465

180

4

Ephrin type-B receptor 4

2×9F

UNN

−83.961

−38.83

2.16227144

140

5

STE20-like serine/threonine-protein kinase

2J51

DKI

−71.754

−33.967

2.112462096

140

6

Mitogen-activated protein kinase 14

1WBW

LI4

−81.464

−42.498

1.916890207

2

7

HTH-type transcriptional regulator TtgR

2UXH

QUE

−100.838

−55.277

1.824230693

ND

8

Serine/threonine-protein kinase pim-1

3MA3

01I

−89.67

−50.377

1.779978959

61

9

Bone morphogenetic protein receptor type-1B

3MDY

LDN

−78.885

−44.586

1.769277352

5000 (Kd)

10

Activin receptor type-1

3MTF

A3F

−80.671

−45.83

1.760222562

614 (Kd)

11

Mitogen-activated protein kinase 10

2O2U

738

−85.273

−49.501

1.722652068

400 (Ki)

12

Cyclin-dependent kinase 2

2IW6

QQ2

−80.586

−51.35

1.569347614

44000

13

Insulin-like growth factor 1 receptor

2ZM3

575

−75.531

−48.801

1.547734678

22900

14

Cyclin-dependent kinase 2

2W17

I19

−79.496

−51.79

1.534968141

60

15

Serine/threonine-protein kinase Chk1

2BRH

DFW

−70.09

−45.808

1.530082082

9.7

16

Tyrosine-protein kinase ITK/TSK

3V8T

477

−83.127

−54.685

1.520106062

0.3